Response to ado-trastuzumab emtansine according to RANO criteria in central nervous system metastases of HER2 positive breast cancers. Role of tumor infiltrating lymphocytes (TILs) in HER2+ metastatic ...
Recommended phase (Ph) II dose (RP2D) selection for investigational Aurora A kinase (AAK) inhibitor MLN8237 (Alisertib; A) combined with paclitaxel (P): Clinical pharmacokinetics (PK), drug-drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results